Five9 Insider Sales: Dignan Sells Shares Under 10b5-1 Plan
Rhea-AI Filing Summary
Five9, Inc. reporting person Andy Dignan sold shares on 09/04/2025 and 09/05/2025. The transactions include three non-derivative sales: 3,402 shares sold on 09/04/2025 at a weighted average price of $25.72, 4,212 shares sold on 09/04/2025 at a weighted average price of $25.28, and 700 shares sold on 09/05/2025 at $26.48. After these sales, the reporting person beneficially owned 217,425 shares.
The filing states the 09/04/2025 sales were mandated by Five9 to cover tax withholding on vested restricted stock units, and the 4,212-share and 700-share sales were effected under a Rule 10b5-1 trading plan adopted December 10, 2024. The form is signed by an attorney-in-fact on behalf of the reporting person.
Positive
- Sales were executed under a Rule 10b5-1 trading plan adopted 12/10/2024, indicating pre-planned transactions
- Company-mandated sale to cover tax withholding on RSU vesting reduces likelihood these were discretionary insider trades
Negative
- None.
Insights
TL;DR: Insider sold shares largely to cover tax obligations; sales executed under a 10b5-1 plan indicate pre-planned disposition.
The Form 4 discloses routine insider selling: mandated broker sales to satisfy tax withholding on vested restricted stock units and additional sales executed pursuant to a Rule 10b5-1 plan adopted 12/10/2024. The filing provides specific share counts and weighted-average prices for the transactions, and reports remaining beneficial ownership at 217,425 shares. From an investor-information perspective, these disclosures are procedural rather than indicative of a change in corporate performance or governance. The filing commits to provide detailed per-trade price breakdowns upon request, which supports transparency.
TL;DR: Transactions appear compliant and administrative; use of 10b5-1 and company-mandated tax-withholding sales are standard practice.
The report documents compliance mechanisms: company-mandated sales to satisfy tax liabilities on RSU vesting and sales under a pre-established 10b5-1 trading plan. Such actions typically reduce the risk of ad-hoc insider trading concerns. The signature by an attorney-in-fact is noted, and the filer offers to provide granular pricing information on request. There is no indication in the form of discretionary opportunistic sales tied to nonpublic developments.